Small cap green stocks Eco Depot Inc (OTCMKTS: ECDP), Eco Building Products Inc (OTCMKTS: ECOB) and Profire Energy, Inc (OTCBB: PFIE) has been getting some extra attention lately in various investment newsletters thanks to paid promotions or investor relation campaigns. Of course, there is nothing wrong with properly disclosed promotions and investor relations campaigns, but small cap green stocks tend to be extra volatile when compared with other stocks. So how in greenbacks will these three small cap green stocks produce for investors? Here is a quick reality check:
Eco Depot Inc (OTCMKTS: ECDP) Has the Swiss Army Knife of Water PurifiersSmall cap Eco Depot Inc was formerly an "eco lighting" distributor under new management as the company is in the development stage of transitioning into a manufacturer and distributor of eco friendly consumer brand products. On Friday, Eco Depot Inc fell 6.06% to $0.0930 for a market cap of $4.54 million plus ECDP is up 210% over the past year and down 79.8% over the past five years according to Google Finance.
Top 10 Oil Companies To Own For 2015: Hutchinson Technology Inc (HTCH)
Hutchinson Technology Incorporated (HTI), incorporated on October 29, 1965, is a global technology manufacturer. The Company is a supplier of suspension assemblies for hard disk drives. The Company operates in two segments: the Disk Drive Components Division and the BioMeasurement Division. The Company manufactures suspension assemblies for all sizes and types of hard disk drives. Suspension assemblies are components of disk drives that hold the read/write heads in position above the spinning magnetic disks.
The Company categorize its products as either suspension assemblies or other revenue, which consists primarily of revenue outside of the disk drive industry for precision component manufacturing, tool design, tool build and metrology, suspension assembly components, reimbursement for disk drive industry-related engineering services and specific disk drive program capacity and biomeasurement products. During the year ended September 29, 2013, the Company shipped 404 million suspension assemblies of all types, supplying all manufacturers of disk drives and head-gimbal assemblers.
The Company competes with Nihon Hatsujo Kabusikigaisha, Magnecomp Precision Technology Public Company Limited, NAT Peripheral (H.K.) Co., Ltd., Nitto Denko Corporation and Dai Nippon Corporation.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 electronic component player that's starting to move within range of triggering a big breakout trade is Hutchinson Technology (HTCH), which is a technology manufacturer that creates value by developing solutions to critical customer problems. This stock has been on fire during 2013, with shares up a whopping 75%.
If you take a look at the chart for Hutchinson Technology, you'll notice that this stock has been finding significant buying interest over the last two months, whenever it has pulled back to around $3.30 to $3.20 a share. This pattern could be signaling that shares of HTCH are forming a major bottoming chart pattern if those levels can hold as support. Shares of HTCH are now starting to flirt with its 50-day moving average at $3.56 a share. That move is starting to push the stock within range of triggering a big breakout trade above a key downtrend line.
Market players should now look for long-biased trades in HTCH if it manages to break out above its 200-day moving average of $3.65 a share and then once it clears more overhead resistance levels at $3.89 to $4.13 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 392,134 shares. If that breakout triggers soon, then HTCH will set up to re-test or possibly take out its next major overhead resistance levels at $4.75 to $5.50 a share, or even $6 a share.
Traders can look to buy HTCH off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.37 or at $3.17 a share. One can also buy HTCH off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
10 Best Building Product Stocks To Invest In Right Now: (AMC)
AMC Entertainment Holdings, Inc., through its subsidiaries, operates as a theatrical exhibition company in the United States and internationally. As of June 30, 2011, it owned, operated, or had interests in 357 theatres and 5,098 screens in 31 states and the District of Columbia, and 4 countries outside the United States. The company was founded in 1920 and is headquartered in Kansas City, Missouri. As of August 30, 2012, AMC Entertainment Holdings, Inc. operates as a subsidiary of Dalian Wanda Group Corporation Ltd.
Advisors' Opinion:- [By Rick Aristotle Munarriz]
Frederic J. Brown, AFP/Getty Images Moviegoers aren't heading out the multiplex the way they used to, but that doesn't mean that Hollywood is toast. AMC Entertainment (AMC) reported quarterly results Tuesday. The nation's leading exhibitor -- 345 theaters with 4,976 screens -- went public two months ago. The headline numbers are positive. Revenue increased a better than expected 2.3 percent to $713 million. Profitability also expanded nicely. However, revenue increased as a result of a 5.5 percent increase in ticket prices and a 3.7 percent uptick in concessions purchased by patrons. Obviously you don't see those kind of gains against a mere 2.3 percent lift in revenue without dealing with more empty seats, and that's just what happened. There was a 3.2 percent decline in attendance. AMC's ticket takers welcomed 50.4 million guests during the holiday quarter, well below the 52.1 million guests that it entertained a year earlier. That's bad, and what makes things worse is that it had fewer theaters -- from continuing operations -- a year earlier. It wouldn't be wise to hold out for a Hollywood ending. Customers Want Bigger and Better Things Apologists will argue that it wasn't a bumper crop of movies hitting theaters, but that's not accurate at all. Last year's biggest box office winner -- "The Hunger Games: Catching Fire" -- opened in November. Disney's "Frozen" also opened ahead of the holidays, and it's the family entertainment giant's biggest non-Pixar earner since 1994's "The Lion King." Moviegoers still come out for the big movies, and they're also willing to pay more for a premium setting. IMAX (IMAX) reported blowout quarterly results a few days earlier. IMAX screens rang up a record $244 million in ticket sales worldwide. IMAX is also closing out the year with a record backlog of 384 commercial theaters to deploy. RealD (RLD) is also holding up nicely as a leading provider of 3-D systems for exhibitors. It enjoyed a major boost with "Gravity," a
- [By Rick Aristotle Munarriz]
Getty Images From a popular multiplex operator going public to a retailer getting hacked at the worst possible time, here's a rundown of the week's best and worst news from the business world. Chipotle Mexican Grill (CMG) -- Winner Chipotle is getting a new stamp in its ethnic cuisine passport. Having mastered Mexican, it was already giving Asian a shot with its new ShopHouse chain. And now, we can add Italian to its map after Chipotle revealed this week that it's a financial backer of Pizzeria Locale. The fast casual concept gives pizza a Chipotle-like makeover with folks ordering at the counter, customizing their 11-inch pies along the assembly line, after which they are baked in a speedy oven that serves up tasty pies in just two minutes. Chipotle's growing just fine with its flagship burrito chain, but it never hurts to diversify before expansion-fueled growth plateaus, or tastes change. Target (TGT) -- Loser Holiday shopping at Target may ultimately prove to more trouble than bargain seekers were hoping for this season. The cheap chic discounter revealed that hackers installed software that stole the info on more than 40 million credit and debit card transactions from Nov. 27 through Dec. 15. This is naturally going to be bad news for those that had their plastic compromised. Everyone that shopped at Target this season is being advised to carefully look over their statements. However, it's also very bad for the retailer at the worst possible time. Shoppers may not be too comfortable heading into Target during these last few shopping days before Christmas. AMC Entertainment (AMC) -- Winner Lights! Camera! IPO action! It may not have been the blockbuster IPO of the year, but the debut of the leading movie theater chain proved to be a success this week. AMC Entertainment went public at $18, opening 7 percent higher and staying above its IPO price. The leading exhibitor operates 343 movie theaters housing 4,950 screens. AMC entertains 200 million guests
10 Best Building Product Stocks To Invest In Right Now: Active Control Techn (ACTV)
The Active Network, Inc. provides organization-based cloud computing applications services to business customers in North America, Europe, and internationally. The company offers ActiveWorks, an organization-based cloud computing platform, which transforms the way organizers record, track, manage, and share information regarding activities and events. Its ActiveWorks back-office system pulls customers� participant management, operational reporting, volunteer management, and service and payment processing functions into one hosted system. The company also provides consulting services, which consist primarily of business mapping, project management services, and guidance on best practices in using its services; and implementation services, including system set-up and configuration, and data conversion, as well as develops customized training and education programs relating to both the use and administration of its services. It serves a range of customers, including communit y and sports organizations, large corporations, small and medium-sized businesses, educational institutions, federal and state government agencies, non-profit organizations, and other related entities. The company was formerly known as Racegate.com, Inc. and changed its name to The Active Network, Inc. in May 2001. The Active Network, Inc. was founded in 1998 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Eric Volkman]
Active Network (NYSE: ACTV ) is on the hunt for a new chief executive following the resignation of Matthew Landa. His place will be taken, on an interim basis, by Jon Belmonte. The appointment is effective immediately. Belmonte is the firm's former chief media officer and COO.
10 Best Building Product Stocks To Invest In Right Now: U.S. Silica Holdings Inc (SLCA)
US Silica Holdings, Inc. is a silica sand supplier company. The Company is a producer of industrial minerals, including sand proppants, whole grain silica, ground silica, fine ground silica, calcined kaolin clay and aplite clay. The Company operates in two segments: oil and gas, and industrial and specialty products. The Company�� shipping capabilities include five of the class-one railroads, barge, full truckload, partial truckload and intermodal. The Company�� products include proppants, whole grain silica, ground silica, fine ground silica, testing silica, recreational silica, aplite, kaolin, hydrous kaolin and FLORISIL. It also operates as a research and development specialist for customized products and solutions. The Company serves a range of industries and applications, which includes oil and gas, glass, chemicals, foundry, building products, fillers and extenders, recreation, industrial filtration and treatment, and testing and analysis.
Oil & Gas
The Company�� oil and gas segment include OTTAWA WHITE and SHALE FRAC product lines. The Company has a selection of offerings from number of mining and transload locations. Its products consist of unconventional reservoirs, including tight gas, coal bed methane, shale gas, and liquids.
Industrial & Specialty Products
The Company�� industrial and specialty products include glass, chemical, foundry, building products, fillers and extenders, recreation, industry filtration and treatment, and testing and analysis. The Company produces a range of whole grain silica, ground silica and kaolin clays.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on U.S. Silica Holdings (NYSE: SLCA ) , whose recent revenue and earnings are plotted below. - [By Alex Planes]
Hi-Crush Partners (NYSE: HCLP ) and U.S. Silica Holdings (NYSE: SLCA ) could also pose a threat to CARBO's higher-end products. CARBO has worked feverishly to convince drillers that ceramic proppants are much stronger than sand, and can withstand the high temperatures and pressures of deep, fractured wells. Since Hi-Crush's IPO, however, it does appear that the tide has shifted to sand, as Carbo's revenues have declined�while Hi-Crush and U.S. Silica have gained. Increased competition from a number of Chinese companies that have flooded the domestic market with cheap ceramic proppants is also a danger to CARBO's higher-quality products, provided that the cut-rate ceramics are actually up to the task.
- [By Jake L'Ecuyer]
U.S. Silica Holdings (NYSE: SLCA) shares tumbled 1.86 percent to $32.15 after the company priced 11.5 million shares at $31.50 per share for selling holders.
- [By MONEYMORNING.COM]
This time let's use U.S. Silica Holdings Inc. (NYSE: SLCA), which we've been following in Strategic Tech Investor for most of this year. We've already made a double on it, and it's trading at near record highs.
10 Best Building Product Stocks To Invest In Right Now: Onconova Therapeutics Inc (ONTX)
Onconova Therapeutics, Inc. (Onconova), incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways, which promote cancer. It has three clinical-stage product candidates and six preclinical programs. Its preclinical pipeline includes six programs, which target kinases, cellular metabolism or division.
Rigosertib
Rigosertib, the Company�� product candidate, is being tested in a range of ongoing Phase-II and Phase-III clinical trials. The Company is conducting a pivotal phase-III trial of rigosertib under a Special Protocol Assessment (SPA), from the United States Food and Drug Administration (FDA), for higher risk myelodysplastic syndromes (MDS). The Company is also evaluating rigosertib in a Phase-III trial for metastatic pancreatic cancer, in two Phase-II trials for transfusion-dependent lower risk MDS, and in a Phase-II trial for head and neck cancers. Rigosertib has been granted orphan drug status for MDS in both the United States and Europe, as well as orphan drug status for pancreatic cancer in the United States. Baxter Healthcare SA (Baxter), a subsidiary of Baxter International Inc., has commercialization rights for rigosertib in Europe and SymBio Pharmaceuticals Limited (SymBio), has commercialization rights in Japan and Korea. Rigosertib is an inhibitor of two cellular signaling pathways: phosphoinositide 3-kinase (PI3K), and polo-like kinase (PLK), both of which are frequently over-active in cancer cells. By inhibiting the PI3K pathway in cancer cells, rigosertib promotes tumor cell apoptosis, or programmed cell death. It is testing both intravenous and oral formulations of rigosertib, referred to as rigosertib IV and rigosertib Oral, in clinical trials.
ON 013105
The Company�� clinical-stage product candidate, ON 013105, is i! n a Phase I trial in patients with relapsed or refractory lymphoma, including an aggressive form of non-Hodgkin's lymphoma identified as mantle cell lymphoma (MCL), and acute lymphoid leukemia (ALL). ON 013105 suppresses the accumulation of cyclin D1 in cancer cells.
Recilisib
The Company�� clinical-stage product candidate, recilisib, is being developed in collaboration with the United States Department of Defense (DoD), for acute radiation syndromes (ARS). The Company has completed four Phase-I trials to evaluate the safety and pharmacokinetics of recilisib in healthy human adult subjects using both subcutaneous and oral formulations, referred to as recilisib SC and recilisib Oral.
Preclinical Programs
The Company�� ON 1231320 is a specific inhibitor of Polo-like Kinase 2 (PLK2), and in preclinical studies, it induced mitotic arrest and reduced tumor burden in mice injected subcutaneously with colon tumor and triple-negative breast cancer cells. The Company�� ON 123300 inhibits the activity of two kinases, cyclin-dependent kinase 4 (CDK4), and AMP-activated protein kinase 5 (ARK5). Its ON 108600 is a dual inhibitor of two growth-regulatory kinases. Cyclin-dependent kinase 9 is over expressed in several cancers, including leukemias and lymphomas. Casein kinase 2 is overexpressed in a range of tumor types. ON 044580 inhibits mutant forms of the two target kinases, including Janus Kinase 2 (JAK2) and imatinib-resistant Bcr-Abl Kinase (Bcr-Abl). Its ON 24 compounds cause tubulin to depolymerize, inducing mitotic arrest in cultured tumor cell lines. Its ON 146040 inhibits the growth of a range of blood cancer cell lines, including Burkitt's lymphoma, MCL, multiple myeloma and chronic myeloid leukemia.
The Company competes with Eisai Inc., Celgene Corporation, Genentech, Inc., Cell Therapeutics, Inc., Cyclacel Pharmaceuticals, Inc., Telik, Inc., Spectrum Pharmaceuticals, Inc., Astex, Array BioPharma Inc., Astellas Pharma, Inc., Threshold! Pharmace! uticals, Inc., Pharmacyclics Inc., Soligenix, Inc., Cellerant Therapeutics, Inc. and Cleveland BioLabs, Inc.
Advisors' Opinion:- [By Roberto Pedone]
Onconova Therapeutics (ONTX), a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. This stock closed up 2.5% to $5.15 in Thursday's trading session.
Thursday's Range: $4.97-$5.19
52-Week Range: $4.10-$31.13
Thursday's Volume: 132,000
Three-Month Average Volume: 216,102From a technical perspective, ONTX trended modestly higher here with lighter-than-average volume. This stock has been uptrending over the last few weeks, with shares moving higher from its low of $4.10 to its recent high of $5.52. During that uptrend, shares of ONTX have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ONTX within range of triggering a near-term breakout trade. That trade will hit if ONTX manages to take out Thursday's intraday high of $5.19 to some more key overhead resistance at $5.52 with high volume.
Traders should now look for long-biased trades in ONTX as long as it's trending above some near-term support levels at $4.80 or at $4.50 and then once it sustains a move or close above those breakout levels with volume that hits near or above 216,102 shares. If that breakout gets underway soon, then ONTX will set up to re-test or possibly take out its next major overhead resistance levels at $5.83 to $6.27. Any high-volume move above those levels will then give ONTX a chance to tag $7.
- [By gurujx]
Onconova Therapeutics Inc (ONTX) Reached the 3-year Low of $4.18
The prices of Onconova Therapeutics Inc (ONTX) shares have declined to close to the 3-year low of $4.18, which is 86.8% off the 3-year high of $31.13.
10 Best Building Product Stocks To Invest In Right Now: Ascent Media Corporation(ASCMA)
Ascent Capital Group, Inc., through its subsidiary, Monitronics International, Inc., provides security alarm monitoring and related services to residential and business subscribers in the United States and Canada. The company is involved in monitoring signals arising from burglaries, fires, medical alerts, and other events, as well as provides customer service and technical support. It also provides central station monitoring services on a wholesale basis for other independent alarm companies that do not have the capability to monitor systems for their customers. In addition, Ascent Capital Group, Inc. offers a range of residential security services, including hands-free two-way voice communication with the monitoring center, cellular options, and an interactive service option, which allows the customer to control their security system using a computer or smart phone. The company markets its services through a network of authorized dealers. Ascent Capital Group, Inc. is ba sed in Greenwood Village, Colorado.
Advisors' Opinion:- [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]
Both of these stocks are overlooked, undervalued, and cash flow machines. The companies are Ascent Capital Group (ASCMA) and Covanta Holdings (CVA).
10 Best Building Product Stocks To Invest In Right Now: ONYX Pharmaceuticals Inc.(ONXX)
Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally. The company, through its collaboration agreement with Bayer HealthCare Pharmaceuticals, Inc., develops and markets Nexavar (sorafenib) tablet, a multiple kinase inhibitor for the treatment of liver cancer and advanced kidney cancer. It is also conducting Phase III clinical trial on Nexavar for the treatment of kidney, liver, lung, thyroid, breast, and non-small cell lung cancers; clinical trials on carfilzomib, a proteasome inhibitor for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors; and Phase Ib/II clinical trial on Oprozomib, an oral proteasome inhibitor. In addition, Onyx Pharmaceuticals, Inc. is developing ONX 0914, an immunoproteasome inhibitor, which is in preclinical stage for the treatment of autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease, and lupus. Further, the company, through its collaboration agreement with Bayer HealthCare Pharmaceuticals, Inc., is conducting clinical trials on Regorafenib, a multi-kinase inhibitor to treat metastatic colorectal cancer and gastrointestinal stromal tumors. It has a collaboration agreement with Warner-Lambert Company to discover and commercialize small molecule drugs that restore control of or intervene in the misregulated cell cycle in tumor cells. The company also has development and license agreements with BTG International Limited for the development and commercialization of ONX 0801, a novel targeted oncology compound; and Ono Pharmaceutical Co., Ltd. to develop and commercialize carfilzomib and Oprozomib for oncology indications in Japan. Onyx Pharmaceuticals, Inc. was founded in 1992 and is headquartered in South San Francisco, California.
Advisors' Opinion:- [By Kyle Anderson, Associate Editor - November 12th, 2013 Money Morning]
Here's the list of top 10 "cash-rich" companies in the S&P 500, based on cash, cash equivalents, and short-term investments, plus how they used the cash they did spend:
General Electric Co. (NYSE: GE) reported cash and cash equivalents of $130.3 billion in September 2013, down slightly from $132.4 billion in June and $138 billion in March. Currently, GE offers its shareholders a dividend of $0.76 per year, or 2.8%. Early in 2013, it was reported that GE planned on buying back $10 billion of its stock from investors. The buyback was prompted by GE selling 49% stake in NBC Universal to Comcast Corp in March. In April, GE acquired the Texas-based oil company Lufkin Industries for $3.3 billion. Microsoft Corp. (Nasdaq: MSFT) had a total of $80.6 billion in cash and short-term investments at the end of September. This was the fourth consecutive quarter of growth for the company that reported $77 billion in June, $74.4 billion in March, and $68.2 billion in December 2012. MSFT provides its shareholders with a 3% dividend, or $1.12 per year. In September, MSFT made headlines for its $40 billion stock buyback and 22% dividend increase. In the same month, Microsoft completed a $7.2 billion acquisition of Nokia Corp.'s (NYSE: NOK) cellphone business. Google Inc. (Nasdaq: GOOG) is third with a cash and short-term investment hoard of $56.4 billion as of September. Google is another company that has added to its cash total in recent quarters, reporting $54.3 billion in June and $50.0 billion in March. Despite all that cash, GOOG does not issue a dividend and has never offered a shareholder buyback. The search engine mogul has a long history of acquisitions, and its purchase of Israeli navigation software Waze, for just shy of $1 billion in June 2013, was its largest in several years. Cisco Systems Inc. (Nasdaq: CSCO) had $50.5 billion in its July statement, compared to $47.3 billion and $46.3 billion in the previous two quar - [By Rich Smith]
Finally, Standpoint argues that Pfizer appears tempted to get into a bidding war with Amgen (NASDAQ: AMGN ) over Onyx Pharmaceuticals (NASDAQ: ONXX ) . On the one hand, the analyst thinks this is a war Pfizer can win. On the other hand, a win at, say, a $10 billion price, to acquire Onyx's potential $1 billion revenue stream (in 2015), would both add significantly to Pfizer's $5 billion net-debt load, while at the same time failing to move the needle much on Pfizer's $57 billion annual revenue stream.
No comments:
Post a Comment